Collection of the Thrombo-VaxCov Cohort (THROMBO-VAXCOV)

University Hospital, Lille

Status: Enrolling

Conditions: Thrombocytopenia; Vaccination; Complications; SARS-CoV Infection; Covid19; Venous Thrombosis

Treatments: Other: Retrospective data and biological samples

Study type: Observational

Funder types: Other

Identifiers

NCT04889326

ECH_2021_cb

Details and patient eligibility

About

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation.

This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.

Full description

In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after anti-Covid vaccination.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

atypical thrombosis symptoms onset within 4 weeks of vaccination

Exclusion criteria

children

Trial design

100 participants in 1 patient group

patient hospitalized with atypical thrombosis within 4 weeks of anti-covid vaccination

Treatment:

Other: Retrospective data and biological samples